Opioid medications: an emerging cancer risk factor?

Br J Anaesth. 2023 Mar;130(3):e401-e403. doi: 10.1016/j.bja.2022.12.007. Epub 2023 Jan 20.

Authors

Mahdi Sheikh¹, Paul Brennan², Daniela Mariosa², Hilary A Robbins²

Affiliations

¹ Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Electronic address: sheikhm@iarc.who.int.
² Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

PMID: 36682937
DOI: 10.1016/j.bja.2022.12.007

No abstract available

Keywords: Mendelian randomisation; analgesics; cancer; carcinogen; opioids; opium; risk factor.

Publication types

Letter

MeSH terms

Analgesics, Opioid / adverse effects
Humans
Neoplasms* / drug therapy
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / epidemiology
Risk Factors

Substances

Analgesics, Opioid

Grants and funding

001/WHO_/World Health Organization/International